A record of what InCred Equities Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Recommends adding Thyrocare Technologies, identifying it as a standout small-cap with 223% upside potential, the highest across all categories. This is a high-conviction pick for December 2025.”
InCred Equities Analysis’s track record (trackable calls only): 14 graded calls · 95% CI 12–55%
Thyrocare Technologies LtdBullishCalled 10 Dec 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee InCred Equities Analysis’s full track record